Literature DB >> 8843863

Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression.

A D Cook1, M J Rowley, I R Mackay, A Gough, P Emery.   

Abstract

OBJECTIVE: To establish that frequencies and levels of IgG antibodies to type II collagen are higher in early rheumatoid arthritis (RA), and to correlate these results with disease activity.
METHODS: Forty-four patients were characterized as having early RA. Patient sera obtained at initial presentation and at 12 months were tested by enzyme-linked immunosorbent assay for IgG antibodies to native and denatured type II collagen.
RESULTS: IgG antibodies to native and denatured type II collagen were detected at initial presentation in 27% and 82% of patients, respectively, and after 12 months in 14% and 50%, respectively. The presence of antibodies to native collagen was associated with activity of RA and severity of symptoms, and loss of antibodies at 12 months was associated with initially erosive RA and the DRB1 disease susceptibility motif.
CONCLUSION: Levels of serum IgG antibodies to collagen in RA decrease over time and, therefore, are not attributable simply to cartilage destruction. The presence of early positivity for these antibodies, together with the RA susceptibility motif, appears to be predictive of rapidly progressive RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843863     DOI: 10.1002/art.1780391015

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  42 in total

1.  Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritis.

Authors:  Max Brenner; Teresina Laragione; Anish Shah; Adriana Mello; Elaine F Remmers; Ronald L Wilder; Pércio S Gulko
Journal:  Arthritis Rheum       Date:  2012-05

2.  Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

Authors:  E C Andersson; B E Hansen; H Jacobsen; L S Madsen; C B Andersen; J Engberg; J B Rothbard; G S McDevitt; V Malmström; R Holmdahl; A Svejgaard; L Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 3.  Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.

Authors:  Anca I Catrina; Camilla I Svensson; Vivianne Malmström; Georg Schett; Lars Klareskog
Journal:  Nat Rev Rheumatol       Date:  2016-12-15       Impact factor: 20.543

4.  A critical role for plasma kallikrein in the pathogenesis of autoantibody-induced arthritis.

Authors:  Aizhen Yang; Junsong Zhou; Bo Wang; Jihong Dai; Robert W Colman; Wenchao Song; Yi Wu
Journal:  FASEB J       Date:  2017-08-14       Impact factor: 5.191

5.  Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.

Authors:  Inger Gjertsson; Karen L Laurie; James Devitt; Steven J Howe; Adrian J Thrasher; Rikard Holmdahl; Kenth Gustafsson
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

6.  The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.

Authors:  Mae-Xhum Wong; John D Hayball; P Mark Hogarth; Denise E Jackson
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

7.  Autoimmunity against fibrinogen mediates inflammatory arthritis in mice.

Authors:  Peggy P Ho; Lowen Y Lee; Xiaoyan Zhao; Beren H Tomooka; Ricardo T Paniagua; Orr Sharpe; Maya J BenBarak; Piyanka E Chandra; Wolfgang Hueber; Lawrence Steinman; William H Robinson
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 8.  Update on autoantibodies in rheumatoid arthritis.

Authors:  S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

9.  Anti-collagen type II antibodies in patients with very early synovitis.

Authors:  K Raza; M Mullazehi; M Salmon; C D Buckley; J Rönnelid
Journal:  Ann Rheum Dis       Date:  2008-09       Impact factor: 19.103

10.  Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.

Authors:  S Carlsén; A S Hansson; H Olsson; D Heinegård; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.